Chen Q - Search Results

1

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.

Goldstein DA, Chen Q, Ayer T, Chan KKW, Virik K, Hammerman A, Brenner B, Flowers CR, Hall PS. Goldstein DA, et al. Among authors: chen q. Oncologist. 2017 Jun;22(6):694-699. doi: 10.1634/theoncologist.2016-0455. Epub 2017 Jun 7. Oncologist. 2017. PMID: 28592621 Free PMC article.

2

Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Harvey RD, El-Rayes BF, Flowers CR. Goldstein DA, et al. Among authors: chen q. Clin Colorectal Cancer. 2014 Dec;13(4):219-25. doi: 10.1016/j.clcc.2014.09.007. Epub 2014 Sep 21. Clin Colorectal Cancer. 2014. PMID: 25306485

3

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR. Goldstein DA, et al. Among authors: chen q. J Clin Oncol. 2015 Apr 1;33(10):1112-8. doi: 10.1200/JCO.2014.58.4904. Epub 2015 Feb 17. J Clin Oncol. 2015. PMID: 25691669 Free PMC article.

4

Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphoma.

Chen Q, Ayer T, Nastoupil LJ, Rose AC, Flowers CR. Chen Q, et al. Value Health. 2015 Mar;18(2):189-97. doi: 10.1016/j.jval.2014.12.017. Value Health. 2015. PMID: 25773554 Free PMC article. Clinical Trial.

5

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.

Goldstein DA, Ahmad BB, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR. Goldstein DA, et al. Among authors: chen q. J Clin Oncol. 2015 Nov 10;33(32):3727-32. doi: 10.1200/JCO.2015.61.9569. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304904 Free PMC article.

6

Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Ramalingam SS, Khuri FR, Flowers CR. Goldstein DA, et al. Among authors: chen q. JAMA Oncol. 2015 Dec;1(9):1293-300. doi: 10.1001/jamaoncol.2015.3316. JAMA Oncol. 2015. PMID: 26313558 Clinical Trial.

7

Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.

Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR. Kohn CG, et al. Among authors: chen q. J Clin Oncol. 2017 Apr 10;35(11):1194-1202. doi: 10.1200/JCO.2016.69.6336. Epub 2017 Feb 21. J Clin Oncol. 2017. PMID: 28221865 Free PMC article.

8

Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.

Chen Q, Staton AD, Ayer T, Goldstein DA, Koff JL, Flowers CR. Chen Q, et al. Leuk Lymphoma. 2018 Jul;59(7):1700-1709. doi: 10.1080/10428194.2017.1390230. Epub 2017 Oct 25. Leuk Lymphoma. 2018. PMID: 29065744 Free PMC article.

9

Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al.

Goldstein DA, El-Rayes BF, Chen Q, Flowers CR. Goldstein DA, et al. Among authors: chen q. J Clin Oncol. 2015 Nov 10;33(32):3842-3. doi: 10.1200/JCO.2015.62.9279. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304876 No abstract available.

10

Sensitivity Analysis in Sequential Decision Models.

Chen Q, Ayer T, Chhatwal J. Chen Q, et al. Med Decis Making. 2017 Feb;37(2):243-252. doi: 10.1177/0272989X16670605. Epub 2016 Sep 29. Med Decis Making. 2017. PMID: 27681992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34,276 results

Search Page